INS and Hyperglycemia: Every 1% increase in HbA1c was associated with a 300% (95% CI: 2.35–3.87) increase in the odds of using basal-bolus insulin therapy, and every 10% increase in the incidence of hyperglycemia increased the chance of administering basal-bolus insulin therapy by 50% (95% CI: 1.35–1.66).